Annual Current Ratio
5.07
-5.72-53.01%
31 December 2023
Summary:
Monte Rosa Therapeutics annual current ratio is currently 5.07, with the most recent change of -5.72 (-53.01%) on 31 December 2023. During the last 3 years, it has risen by +3.58 (+240.27%). GLUE annual current ratio is now -75.81% below its all-time high of 20.96, reached on 31 December 2021.GLUE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Ratio
6.03
-0.53-8.08%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly current ratio is currently 6.03, with the most recent change of -0.53 (-8.08%) on 30 September 2024. Over the past year, it has dropped by -2.06 (-25.46%). GLUE quarterly current ratio is now -81.84% below its all-time high of 33.20, reached on 30 June 2021.GLUE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Current Ratio Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.0% | -25.5% |
| 3 y3 years | +240.3% | -79.3% |
| 5 y5 years | - | - |
GLUE Current Ratio High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -75.8% | +240.3% | -79.3% | +25.1% |
| 5 y | 5 years | -75.8% | +240.3% | -81.8% | +304.7% |
| alltime | all time | -75.8% | +240.3% | -81.8% | +304.7% |
Monte Rosa Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | 6.03(-8.1%) |
| June 2024 | - | 6.56(+36.1%) |
| Mar 2024 | - | 4.82(-4.9%) |
| Dec 2023 | 5.07(-53.0%) | 5.07(-37.3%) |
| Sept 2023 | - | 8.09(-25.8%) |
| June 2023 | - | 10.90(-7.1%) |
| Mar 2023 | - | 11.73(+8.7%) |
| Dec 2022 | 10.79 | 10.79(-20.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | 13.55(-32.6%) |
| June 2022 | - | 20.11(-21.6%) |
| Mar 2022 | - | 25.65(+22.4%) |
| Dec 2021 | 20.96(+1306.7%) | 20.96(-27.9%) |
| Sept 2021 | - | 29.08(-12.4%) |
| June 2021 | - | 33.20(+75.8%) |
| Mar 2021 | - | 18.89(+1167.8%) |
| Dec 2020 | 1.49(-34.4%) | 1.49 |
| Dec 2019 | 2.27 | - |
FAQ
- What is Monte Rosa Therapeutics annual current ratio?
- What is the all time high annual current ratio for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual current ratio year-on-year change?
- What is Monte Rosa Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly current ratio year-on-year change?
What is Monte Rosa Therapeutics annual current ratio?
The current annual current ratio of GLUE is 5.07
What is the all time high annual current ratio for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual current ratio is 20.96
What is Monte Rosa Therapeutics annual current ratio year-on-year change?
Over the past year, GLUE annual current ratio has changed by -5.72 (-53.01%)
What is Monte Rosa Therapeutics quarterly current ratio?
The current quarterly current ratio of GLUE is 6.03
What is the all time high quarterly current ratio for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly current ratio is 33.20
What is Monte Rosa Therapeutics quarterly current ratio year-on-year change?
Over the past year, GLUE quarterly current ratio has changed by -2.06 (-25.46%)